Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 1997

View Archived Issues

ET antagonists from Warner-Lambert claimed for cerebrovascular disorders

MS&D describes tachykinin antagonists

Factor Xa inhibitors from 3-D

Antiischemic potassium channel activators described by BMS

3-D describes potent and selective thrombin inhibitors

MS&D discloses 5-HT1-like receptor agonists

Glutamate antagonists from Warner-Lambert

Pharmacokinetics and tissue distribution of TOP-53

Nippon Shinyaku characterizes novel sulfonamide antitumor agent

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

FDA approves Columbia's Crinone

PAK-104P reverses both P-glycoprotein- and MRP-mediated MDR

Potent, selective, orally active tachykinin NK1 antagonist reported by Menarini

New hypoxic cytotoxin from Evanston Hospital

Cellegy: Q1 1997 highlights

Interneuron: Q2 1997 highlights

Connetics: Q1 1997 highlights

NeoRx: Q1 1997 highlights

Dusa: Q1 1997 highlights

FDA advisory committee recommends Roche's Xenical for weight loss

Cytogen updates stockholders

Elan to market Dainippon's zonisamide in North America

SmithKline Beechan to market Kissei's tranilast

Discovery licenses N-0923 transdermal patch to Yoshitomi

NeoPharm licenses broxuridine to BioChem Therapeutic

Innovative Technologies and Derma Sciences form strategic joint venture

Receptagen receives offer to merge from Generex

Cephalon and Chiron seek European approval of Myotrophin

BMS and RTI form anticancer alliance

Mouse model for idiopathic voiding disorders in humans

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...